Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
137
NCT02263950
A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours
Phase: Phase 1/2
Role: Lead Sponsor
Start: Oct 31, 2014
Completion: Oct 31, 2016
NCT02390986
An Extension Study of LON002 in Patients With Cancer
Phase: N/A
Start: Jan 31, 2015
Completion: Jun 30, 2017